← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Concentra grew revenue, but FCF and margins softened.
The read at a glance✓ Audited against SEC data
- Business mix — Occupational health centers and onsite clinicsNote
- Revenue — $2.16B, +13.9%OK
- Net income — $166.41M, -0.1%Note
- FCF — $197.06M, -6.3%Watch
- Debt — $1.56B, +6.4%Watch
- Altman/Beneish/EQ — Grey Z; clean M/EQNote
- Insiders — 0 purchases / 1 saleWatch
Business
Concentra provides occupational health center, onsite clinic, employer service, and workers compensation healthcare services.
Where the revenue comes from
Fiscal 2025, as Concentra Group Holdings Parent, Inc. reports it. History and quarterly detail are in the app.
- Total occupational health center revenue$2.0B
- Onsite health clinics$110.2M
- Other Businesses$47.5M
Leadership changes
From Concentra Group Holdings Parent, Inc.'s own filings, the day they're filed.
- John R. Anderson · Chief Medical Officer · departureeff. 2026-12-31
- John Anderson · Chief Medical Officer · departureeff. 2026-12-31
- Brigid Bonner · directors · appointmenteff. 2025-07-01
Latest filings
- 8-K · Company announcement2026-08-27
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-10
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Concentra Group Holdings Parent, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.